ClinicalTrials.Veeva

Menu

Hyperglycaemia and Hyperlactataemia in Patients With Severe Acute Brain Injury (BRAIN-GLULAC)

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Hyperlactatemia
Hyperglycemia
Acute Brain Injury

Treatments

Other: Sampling of blood and cerebrospinal fluid

Study type

Observational

Funder types

Other

Identifiers

NCT05505396
P-2022-321

Details and patient eligibility

About

This is an observational study of patients with severe acute brain injury, which aims to characterize the development of hyperglycaemia and hyperlactataemia and the influence of these markers on clinical outcome.

Additionally, in a subgroup of patients undergoing advanced multimodal neuromonitoring on either clinical or research indication, the relationship between hyperglycaemia and brain glucose levels as well as systemic and microdialysis lactate will be examined.

Enrollment

459 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Admission to the neurointensive care unit at Rigshospitalet
  • Diagnosis of acute brain injury categorised as TBI, SAH, ICH, ischaemic stroke, or other conditions

Exclusion criteria

  • Brain death before inclusion
  • Closest relatives do not understand written and spoken Danish or English

Trial contacts and locations

1

Loading...

Central trial contact

Alexandra Vassilieva

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems